wikipedia - 21 Oct 2020 Lymphoma is a group of blood malignancies that develop from lymphocytes (a type of white blood cell).[7] The name often refers to just the cancerous versions rather than all such tumours.[7] Signs and symptoms may include enlarged lymph nodes, fever, drenching sweats, unintended weight loss, itching, and constantly feeling tired.[1][2] The enlarged lymph nodes are usually painless.[1] The sweats are most common at night.[1][2]
BioSpace - 23 May 2022
Antengene Announces First Patient Dosed in the Phase I/II SWATCH Study of XPOVIO® (Selinexor) for the Treatment of B-Cell Non-Hodgkin Lymphomas ...
AJMC.com Managed Markets Network - 22 May 2022
TIGIT May Hold Potential as a Marker of CAR T-Cell Exhaustion and Therapeutic Target in Non-Hodgkin Lymphoma ...
Science Daily - 13 May 2022
Early study finds new lymphoma drug effective: Eighty percent of patients with a subset of lymphoma on a clinical trial saw their cancers shrink after taking zanubrutinib ...
Nature.com - 18 May 2022
NMR-based metabolomic profiling can differentiate follicular lymphoma from benign lymph node tissues and may be predictive of outcome | Scientific Reports ...
The Daily Vale - 23 May 2022
Lymphoblastic Lymphoma Therapeutic Market – A Comprehensive Study by Key Players:Kyowa Kirin, GSK, Novartis – The Daily Vale ...
